Cell-free DNA based cancer diagnostic and screening market US vs. world 2020
This statistic shows a cell-free DNA based cancer diagnostic and screening market forecast for 2020, comparing the U.S. vs. the global market. By 2020, the global market is estimated to be valued at some 3.8 billion U.S. dollars.